Epigenetic regulation of the metallothionein-1A promoter by PU.1 during differentiation of THP-1 cells

Biochemical and Biophysical Research Communications

Volumn 433, Issue 3, 2013, Pages 349-353

  Suzuki, Sawami ^a   Nakano, Hiroko ^a   Takahashi, Shinichiro ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

DNA methylation; Epigenetic regulation; Histone modification; Metallothionein 1A; Monocyte differentiation; PU.1

Indexed keywords

HISTONE H4; METALLOTHIONEIN 1A; METALLOTHIONEIN I; METHYL CPG BINDING PROTEIN 2; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; METHYLATION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION;

ACETYLATION; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; METALLOTHIONEIN; MONOCYTES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS;

EID: 84876319289     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.007     Document Type: Article

References (21)

1. Chen H.M., Zhang P., Voso M.T., Hohaus S., Gonzalez D.A., Glass C.K., Zhang D.E., Tenen D.G. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 1995, 85:2918-2928.
2. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577.
3. Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., Okuno Y., Akashi K., Fiering S., Tenen D.G. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 2004, 36:624-630.
4. Pettersson M., Sundstrom C., Nilsson K., Larsson L.G. The hematopoietic transcription factor PU.1 is downregulated in human multiple myeloma cell lines. Blood 1995, 86:2747-2753.
5. Huh H.J., Chae S.L., Lee M., Hong K.S., Mun Y.C., Seong C.M., Chung W.S., Huh J.W. CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome. Int. J. Lab. Hematol. 2009, 31:344-351.
6. Imoto A., Okada M., Okazaki T., Kitasato H., Harigae H., Takahashi S. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. J. Biol. Chem. 2010, 285:10300-10309.
7. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1982, 42:1530-1536.
8. Hirosawa M., Nakahara M., Otosaka R., Imoto A., Okazaki T., Takahashi S. The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells. Leuk. Res. 2009, 33:693-699.
9. Inomata M., Takahashi S., Harigae H., Kameoka J., Kaku M., Sasaki T. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leuk. Res. 2006, 30:659-664.
10. Aoyama S., Nakano H., Danbara M., Higashihara M., Harigae H., Takahashi S. The differentiating and apoptotic effects of 2-aza-5'-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochem. Biophys. Res. Commun. 2012, 420:775-781.
11. Suzuki M., Yamada T., Kihara-Negishi F., Sakurai T., Oikawa T. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression. Oncogene 2003, 22:8688-8698.
12. Hendrich B., Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 1998, 18:6538-6547.
13. Steidl U., Rosenbauer F., Verhaak R.G., Gu X., Ebralidze A., Otu H.H., Klippel S., Steidl C., Bruns I., Costa D.B., Wagner K., Aivado M., Kobbe G., Valk P.J., Passegue E., Libermann T.A., Delwel R., Tenen D.G. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat. Genet. 2006, 38:1269-1277.
14. Takahashi S. PU.1 a versatile transcription factor and a suppressor of myeloid leukemia. Myeloid Leukemia - Basic Mech. Leukemogenesis 2011, 239-262.
15. Kihara-Negishi F., Yamamoto H., Suzuki M., Yamada T., Sakurai T., Tamura T., Oikawa T. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Oncogene 2001, 20:6039-6047.
16. Fisher R.C., Scott E.W. Role of PU.1 in hematopoiesis. Stem Cells 1998, 16:25-37.
17. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90:489-519.
18. Cherian M.G., Jayasurya A., Bay B.H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. 2003, 533:201-209.
19. Takahashi S. Molecular functions of metallothionein and its role in hematological malignancies. J. Hematol. Oncol. 2012, 5:41.
20. Chiaverini N., De Ley M. Protective effect of metallothionein on oxidative stress-induced DNA damage. Free Radic. Res. 2010, 44:605-613.
21. Weiss S.J., King G.W., LoBuglio A.F. Superoxide generation by human monocytes and macrophages. Am. J. Hematol. 1978, 4:1-8.